BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36337911)

  • 21. Clonal hematopoiesis and atherosclerotic cardiovascular disease: A primer.
    Zuriaga MA; Fuster JJ
    Clin Investig Arterioscler; 2023; 35(1):35-41. PubMed ID: 34879980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal hematopoiesis and VEXAS syndrome: survival of the fittest clones?
    Kusne Y; Fernandez J; Patnaik MM
    Semin Hematol; 2021 Oct; 58(4):226-229. PubMed ID: 34802544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonal hematopoiesis as a model for premalignant changes during aging.
    Steensma DP; Ebert BL
    Exp Hematol; 2020 Mar; 83():48-56. PubMed ID: 31838005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal hematopoiesis, aging, and cardiovascular diseases.
    Pardali E; Dimmeler S; Zeiher AM; Rieger MA
    Exp Hematol; 2020 Mar; 83():95-104. PubMed ID: 31891750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis.
    Menendez-Gonzalez JB; Rodrigues NP
    Methods Mol Biol; 2022; 2419():73-88. PubMed ID: 35237959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of Clonal Hematopoiesis and Risk of Heart Failure.
    Bazeley P; Morales R; Tang WHW
    Curr Heart Fail Rep; 2020 Oct; 17(5):271-276. PubMed ID: 32772279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal hematopoiesis: Pre-cancer PLUS.
    Silver AJ; Jaiswal S
    Adv Cancer Res; 2019; 141():85-128. PubMed ID: 30691686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.
    Wiedmeier JE; Kato C; Zhang Z; Lee H; Dunlap J; Nutt E; Rattray R; McKay S; Eide C; Press R; Mori M; Druker B; Dao KH
    Exp Hematol; 2016 Sep; 44(9):857-865.e5. PubMed ID: 27235757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice.
    Fuster JJ; MacLauchlan S; Zuriaga MA; Polackal MN; Ostriker AC; Chakraborty R; Wu CL; Sano S; Muralidharan S; Rius C; Vuong J; Jacob S; Muralidhar V; Robertson AA; Cooper MA; Andrés V; Hirschi KK; Martin KA; Walsh K
    Science; 2017 Feb; 355(6327):842-847. PubMed ID: 28104796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure.
    Abplanalp WT; Cremer S; John D; Hoffmann J; Schuhmacher B; Merten M; Rieger MA; Vasa-Nicotera M; Zeiher AM; Dimmeler S
    Circ Res; 2021 Jan; 128(2):216-228. PubMed ID: 33155517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of clonal hematopoiesis on non-hematological diseases and aging processes].
    Rieger MA
    Inn Med (Heidelb); 2022 Nov; 63(11):1115-1125. PubMed ID: 36214849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
    Haring B; Wissel S; Manson JE
    Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis.
    Heyde A; Rohde D; McAlpine CS; Zhang S; Hoyer FF; Gerold JM; Cheek D; Iwamoto Y; Schloss MJ; Vandoorne K; Iborra-Egea O; Muñoz-Guijosa C; Bayes-Genis A; Reiter JG; Craig M; Swirski FK; Nahrendorf M; Nowak MA; Naxerova K
    Cell; 2021 Mar; 184(5):1348-1361.e22. PubMed ID: 33636128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal Hematopoiesis of Indeterminate Potential Reshapes Age-Related CVD: JACC Review Topic of the Week.
    Khetarpal SA; Qamar A; Bick AG; Fuster JJ; Kathiresan S; Jaiswal S; Natarajan P
    J Am Coll Cardiol; 2019 Jul; 74(4):578-586. PubMed ID: 31345433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.
    Jaiswal S; Natarajan P; Silver AJ; Gibson CJ; Bick AG; Shvartz E; McConkey M; Gupta N; Gabriel S; Ardissino D; Baber U; Mehran R; Fuster V; Danesh J; Frossard P; Saleheen D; Melander O; Sukhova GK; Neuberg D; Libby P; Kathiresan S; Ebert BL
    N Engl J Med; 2017 Jul; 377(2):111-121. PubMed ID: 28636844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of clonal hematopoiesis in heart failure.
    Chavkin NW; Min KD; Walsh K
    Trends Cardiovasc Med; 2022 May; 32(4):198-203. PubMed ID: 33892102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in understanding the molecular basis of clonal hematopoiesis.
    Alagpulinsa DA; Toribio MP; Alhallak I; Shmookler Reis RJ
    Trends Mol Med; 2022 May; 28(5):360-377. PubMed ID: 35341686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.
    Fuster JJ; Walsh K
    Circ Res; 2018 Feb; 122(3):523-532. PubMed ID: 29420212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal hematopoiesis: Molecular basis and clinical relevance.
    Kunimoto H; Nakajima H
    Leuk Res; 2020 Nov; 98():106457. PubMed ID: 33010619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.